Page last updated: 2024-09-03

sulbactam and ppi-0903

sulbactam has been researched along with ppi-0903 in 1 studies

Compound Research Comparison

Studies (sulbactam)	Trials (sulbactam)	Recent Studies (post-2010) (sulbactam)	Studies (ppi-0903)	Trials (ppi-0903)	Recent Studies (post-2010) (ppi-0903)
1,844	297	488	519	39	451

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Krause, KM; Nichols, WW; Pillar, CM; Shinabarger, DL; Stoneburner, A	1

Other Studies

1 other study(ies) available for sulbactam and ppi-0903

Article	Year
The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria. Letters in applied microbiology, 2016, Volume: 63, Issue:2 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulbactam	2016

Article

Year

The postantibiotic effect and post-β-lactamase-inhibitor effect of ceftazidime, ceftaroline and aztreonam in combination with avibactam against target Gram-negative bacteria.

Letters in applied microbiology, 2016, Volume: 63, Issue:2

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Ceftaroline; Ceftazidime; Cephalosporins; Drug Combinations; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sulbactam

2016